Literature DB >> 13662213

Gout: six-year follow-up on probenecid (benemid) therapy.

E C BARTELS, G S MATOSSIAN.   

Abstract

Entities:  

Keywords:  GOUT/therapy; PROBENECID/therapeutic use

Mesh：

Substances：

Year:  1959        PMID： 13662213     DOI： 10.1002/1529-0131(195906)2:3<193::aid-art1780020302>3.0.co;2-8

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  8 in total

Review 1.  Urate-lowering therapy: current options and future prospects for elderly patients with gout.

Authors:  Lisa K Stamp; Peter T Chapman
Journal:  Drugs Aging       Date:  2014-11       Impact factor: 3.923

Review 2.  EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).

Authors:  W Zhang; M Doherty; T Bardin; E Pascual; V Barskova; P Conaghan; J Gerster; J Jacobs; B Leeb; F Lioté; G McCarthy; P Netter; G Nuki; F Perez-Ruiz; A Pignone; J Pimentão; L Punzi; E Roddy; T Uhlig; I Zimmermann-Gòrska
Journal:  Ann Rheum Dis       Date:  2006-05-17       Impact factor: 19.103

3.  Acute polyarticular gout.

Authors:  D A Raddatz; M L Mahowald; P J Bilka
Journal:  Ann Rheum Dis       Date:  1983-04       Impact factor: 19.103

Review 4.  A benefit-risk assessment of benzbromarone in the treatment of gout. Was its withdrawal from the market in the best interest of patients?

Authors:  Ming-Han H Lee; Garry G Graham; Kenneth M Williams; Richard O Day
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

5.  Pharmacokinetic and pharmacodynamic interaction between allopurinol and probenecid in healthy subjects.

Authors:  Sophie L Stocker; Kenneth M Williams; Andrew J McLachlan; Garry G Graham; Richard O Day
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

Review 6.  Efficacy and safety of urate-lowering therapy in people with kidney impairment: a GCAN-initiated literature review.

Authors:  Hamish Farquhar; Ana B Vargas-Santos; Huai Leng Pisaniello; Mark Fisher; Catherine Hill; Angelo L Gaffo; Lisa K Stamp
Journal:  Rheumatol Adv Pract       Date:  2021-01-04

7.  African American patients with gout: efficacy and safety of febuxostat vs allopurinol.

Authors:  Alvin F Wells; Patricia A MacDonald; Solomon Chefo; Robert L Jackson
Journal:  BMC Musculoskelet Disord       Date:  2012-02-09       Impact factor: 2.362

8.  The efficacy and safety of febuxostat for urate lowering in gout patients ≥65 years of age.

Authors:  Robert L Jackson; Barbara Hunt; Patricia A MacDonald
Journal:  BMC Geriatr       Date:  2012-03-21       Impact factor: 3.921
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.